MEDIPHARM LABS CORP (LABS.CA) Stock Cash Flow
TSX:LABS • CA58504D1006
0.07 CAD
0 (0%)
Last: Mar 10, 2026, 07:00 PM
| TTM (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -8.03M | -10.69M | -13.08M | -29.98M | -54.80M | |||
| Depreciation Amortization | 1.82M | 2.60M | 2.52M | 2.87M | 5.63M | |||
| Income Taxes - Deferred | N/A | N/A | 0.00 | -10.00K | N/A | |||
| Change In Working Capital | -934.00K | 1.65M | 3.45M | 6.25M | 21.83M | |||
| Interest Paid | 59.00K | 300.00K | 264.00K | 30.00K | 10.00K | |||
| Other non cash items | 128.00K | 1.58M | -5.22M | 4.81M | 14.13M | |||
| OPERATING CASH FLOW | -7.01M | -4.86M | -12.34M | -16.07M | -13.21M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -144.00K | -154.00K | -471.00K | -860.00K | -780.00K | |||
| Other Investing Activity | 4.72M | 567.00K | 7.34M | 6.02M | 820.00K | |||
| INVESTING CASH FLOW | 4.58M | 413.00K | 6.87M | 5.16M | 40.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -306.00K | -2.25M | -944.00K | 390.00K | -2.96M | |||
| Stock Issued/Repurchased | N/A | 14.00K | N/A | 0.00 | 30.92M | |||
| Other Financing Activity | 213.00K | 391.00K | 576.00K | 400.00K | -150.00K | |||
| FINANCING CASH FLOW | -79.00K | -1.85M | -368.00K | 800.00K | 27.80M | |||
| Exchange Rate Effect | 1.00K | 4.00K | -329.00K | 150.00K | -430.00K | |||
| CHANGE IN CASH | -2.51M | -6.29M | -6.16M | -9.96M | 14.20M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -7.01M | -4.86M | -12.34M | -16.07M | -13.21M | |||
| Capital Expenditure | -144.00K | -154.00K | -471.00K | -860.00K | -780.00K | |||
| FREE CASH FLOW | -7.15M | -5.01M | -12.81M | -16.93M | -13.99M | |||
All data in CAD